NTV: Stanbic extends UGX 133B credit to QCIL to boost drug production
Released On May 23, 2025
Emmanuel Katongole, Executive Chairman of QCIL, emphasized that the investment will enhance the company's ability to supply essential medicines across Africa.
Latest Media Releases
Qcil Marks 20 Years with Groundbreaking for New Factory and Launch of Paediatric HIV/AIDS Medicine
9 October 2025
Qcil, the region’s leading pharmaceutical manufacturer, today marked a double milestone, celebrating 20 years of pharmaceutical excellence in Sub-Saharan Africa and breaking ground for a new state-of-the-art manufacturing facility at its Luzira Industrial Park campus in Kampala.
Business Focus Magazine: Qcil Beyond Healing
1 September 2025
DEFINED BY ITS HOLISTIC APPROACH TO WELLNESS, AFRICAN PHARMACEUTICAL MANUFACTURER QCIL IS ENABLING MORE FULFILLING LIVES ACROSS THE CONTINENT.
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
27 August 2025
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing
18 July 2025
CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing
Qcil POSTS RECORD PROFITS AND ANNOUNCES AMBITIOUS EXPANSION
17 July 2025
“This expansion will enable us to do more for our patients, our people, and our economy.” said Mr. Katongole.